The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biochips (Microarrays & Microfluidics) Market Research Report 2025
Synopsis
The global Biochips (Microarrays & Microfluidics) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Following a strong growth of 26.2 percent in the year 2021, WSTS revised it down to a single digit growth for the worldwide semiconductor market in 2022 with a total size of US$580 billion, up 4.4 percent. WSTS lowered growth estimation as inflation rises and end markets seeing weaker demand, especially those exposed to consumer spending. While some major categories are still double-digit year-over-year growth in 2022, led by Analog with 20.8 percent, Sensors with 16.3 percent, and Logic with 14.5 percent growth. Memory declined with 12.6 percent year over year. In 2022, all geographical regions showed double-digit growth except Asia Pacific. The largest region, Asia Pacific, declined 2.0 percent. Sales in the Americas were US$142.1 billion, up 17.0% year-on-year, sales in Europe were US$53.8 billion, up 12.6% year-on-year, and sales in Japan were US$48.1 billion, up 10.0% year-on-year. However, sales in the largest Asia-Pacific region were US$336.2 billion, down 2.0% year-on-year.
This report aims to provide a comprehensive presentation of the global market for Biochips (Microarrays & Microfluidics), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biochips (Microarrays & Microfluidics).
Report Scope
The Biochips (Microarrays & Microfluidics) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biochips (Microarrays & Microfluidics) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biochips (Microarrays & Microfluidics) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Agilent
PerkinElmer
Fluidigm
Illumina
GE Healthcare
Bio-Rad Laboratories
Cepheid
Thermo Fisher
Roche
Segment by Type
DNA Chip
Lab-on-a-chip
Protein Chip
Segment by Application
Academics Institutes
Diagnostics Centers
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biochips (Microarrays & Microfluidics) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biochips (Microarrays & Microfluidics) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Biochips (Microarrays & Microfluidics) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Following a strong growth of 26.2 percent in the year 2021, WSTS revised it down to a single digit growth for the worldwide semiconductor market in 2022 with a total size of US$580 billion, up 4.4 percent. WSTS lowered growth estimation as inflation rises and end markets seeing weaker demand, especially those exposed to consumer spending. While some major categories are still double-digit year-over-year growth in 2022, led by Analog with 20.8 percent, Sensors with 16.3 percent, and Logic with 14.5 percent growth. Memory declined with 12.6 percent year over year. In 2022, all geographical regions showed double-digit growth except Asia Pacific. The largest region, Asia Pacific, declined 2.0 percent. Sales in the Americas were US$142.1 billion, up 17.0% year-on-year, sales in Europe were US$53.8 billion, up 12.6% year-on-year, and sales in Japan were US$48.1 billion, up 10.0% year-on-year. However, sales in the largest Asia-Pacific region were US$336.2 billion, down 2.0% year-on-year.
This report aims to provide a comprehensive presentation of the global market for Biochips (Microarrays & Microfluidics), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biochips (Microarrays & Microfluidics).
Report Scope
The Biochips (Microarrays & Microfluidics) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biochips (Microarrays & Microfluidics) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biochips (Microarrays & Microfluidics) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Agilent
PerkinElmer
Fluidigm
Illumina
GE Healthcare
Bio-Rad Laboratories
Cepheid
Thermo Fisher
Roche
Segment by Type
DNA Chip
Lab-on-a-chip
Protein Chip
Segment by Application
Academics Institutes
Diagnostics Centers
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biochips (Microarrays & Microfluidics) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biochips (Microarrays & Microfluidics) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Biochips (Microarrays & Microfluidics) Market Overview
1.1 Product Overview and Scope of Biochips (Microarrays & Microfluidics)
1.2 Biochips (Microarrays & Microfluidics) Segment by Type
1.2.1 Global Biochips (Microarrays & Microfluidics) Market Value Comparison by Type (2024-2030)
1.2.2 DNA Chip
1.2.3 Lab-on-a-chip
1.2.4 Protein Chip
1.3 Biochips (Microarrays & Microfluidics) Segment by Application
1.3.1 Global Biochips (Microarrays & Microfluidics) Market Value by Application: (2024-2030)
1.3.2 Academics Institutes
1.3.3 Diagnostics Centers
1.4 Global Biochips (Microarrays & Microfluidics) Market Size Estimates and Forecasts
1.4.1 Global Biochips (Microarrays & Microfluidics) Revenue 2019-2030
1.4.2 Global Biochips (Microarrays & Microfluidics) Sales 2019-2030
1.4.3 Global Biochips (Microarrays & Microfluidics) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Biochips (Microarrays & Microfluidics) Market Competition by Manufacturers
2.1 Global Biochips (Microarrays & Microfluidics) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Biochips (Microarrays & Microfluidics) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Biochips (Microarrays & Microfluidics) Average Price by Manufacturers (2019-2024)
2.4 Global Biochips (Microarrays & Microfluidics) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biochips (Microarrays & Microfluidics), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biochips (Microarrays & Microfluidics), Product Type & Application
2.7 Biochips (Microarrays & Microfluidics) Market Competitive Situation and Trends
2.7.1 Biochips (Microarrays & Microfluidics) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Biochips (Microarrays & Microfluidics) Players Market Share by Revenue
2.7.3 Global Biochips (Microarrays & Microfluidics) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biochips (Microarrays & Microfluidics) Retrospective Market Scenario by Region
3.1 Global Biochips (Microarrays & Microfluidics) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Biochips (Microarrays & Microfluidics) Global Biochips (Microarrays & Microfluidics) Sales by Region: 2019-2030
3.2.1 Global Biochips (Microarrays & Microfluidics) Sales by Region: 2019-2024
3.2.2 Global Biochips (Microarrays & Microfluidics) Sales by Region: 2025-2030
3.3 Global Biochips (Microarrays & Microfluidics) Global Biochips (Microarrays & Microfluidics) Revenue by Region: 2019-2030
3.3.1 Global Biochips (Microarrays & Microfluidics) Revenue by Region: 2019-2024
3.3.2 Global Biochips (Microarrays & Microfluidics) Revenue by Region: 2025-2030
3.4 North America Biochips (Microarrays & Microfluidics) Market Facts & Figures by Country
3.4.1 North America Biochips (Microarrays & Microfluidics) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Biochips (Microarrays & Microfluidics) Sales by Country (2019-2030)
3.4.3 North America Biochips (Microarrays & Microfluidics) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Biochips (Microarrays & Microfluidics) Market Facts & Figures by Country
3.5.1 Europe Biochips (Microarrays & Microfluidics) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Biochips (Microarrays & Microfluidics) Sales by Country (2019-2030)
3.5.3 Europe Biochips (Microarrays & Microfluidics) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biochips (Microarrays & Microfluidics) Market Facts & Figures by Country
3.6.1 Asia Pacific Biochips (Microarrays & Microfluidics) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Biochips (Microarrays & Microfluidics) Sales by Country (2019-2030)
3.6.3 Asia Pacific Biochips (Microarrays & Microfluidics) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Biochips (Microarrays & Microfluidics) Market Facts & Figures by Country
3.7.1 Latin America Biochips (Microarrays & Microfluidics) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Biochips (Microarrays & Microfluidics) Sales by Country (2019-2030)
3.7.3 Latin America Biochips (Microarrays & Microfluidics) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biochips (Microarrays & Microfluidics) Market Facts & Figures by Country
3.8.1 Middle East and Africa Biochips (Microarrays & Microfluidics) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Biochips (Microarrays & Microfluidics) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Biochips (Microarrays & Microfluidics) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biochips (Microarrays & Microfluidics) Sales by Type (2019-2030)
4.1.1 Global Biochips (Microarrays & Microfluidics) Sales by Type (2019-2024)
4.1.2 Global Biochips (Microarrays & Microfluidics) Sales by Type (2025-2030)
4.1.3 Global Biochips (Microarrays & Microfluidics) Sales Market Share by Type (2019-2030)
4.2 Global Biochips (Microarrays & Microfluidics) Revenue by Type (2019-2030)
4.2.1 Global Biochips (Microarrays & Microfluidics) Revenue by Type (2019-2024)
4.2.2 Global Biochips (Microarrays & Microfluidics) Revenue by Type (2025-2030)
4.2.3 Global Biochips (Microarrays & Microfluidics) Revenue Market Share by Type (2019-2030)
4.3 Global Biochips (Microarrays & Microfluidics) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Biochips (Microarrays & Microfluidics) Sales by Application (2019-2030)
5.1.1 Global Biochips (Microarrays & Microfluidics) Sales by Application (2019-2024)
5.1.2 Global Biochips (Microarrays & Microfluidics) Sales by Application (2025-2030)
5.1.3 Global Biochips (Microarrays & Microfluidics) Sales Market Share by Application (2019-2030)
5.2 Global Biochips (Microarrays & Microfluidics) Revenue by Application (2019-2030)
5.2.1 Global Biochips (Microarrays & Microfluidics) Revenue by Application (2019-2024)
5.2.2 Global Biochips (Microarrays & Microfluidics) Revenue by Application (2025-2030)
5.2.3 Global Biochips (Microarrays & Microfluidics) Revenue Market Share by Application (2019-2030)
5.3 Global Biochips (Microarrays & Microfluidics) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Biochips (Microarrays & Microfluidics) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Biochips (Microarrays & Microfluidics) Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Agilent
6.2.1 Agilent Corporation Information
6.2.2 Agilent Description and Business Overview
6.2.3 Agilent Biochips (Microarrays & Microfluidics) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Agilent Biochips (Microarrays & Microfluidics) Product Portfolio
6.2.5 Agilent Recent Developments/Updates
6.3 PerkinElmer
6.3.1 PerkinElmer Corporation Information
6.3.2 PerkinElmer Description and Business Overview
6.3.3 PerkinElmer Biochips (Microarrays & Microfluidics) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 PerkinElmer Biochips (Microarrays & Microfluidics) Product Portfolio
6.3.5 PerkinElmer Recent Developments/Updates
6.4 Fluidigm
6.4.1 Fluidigm Corporation Information
6.4.2 Fluidigm Description and Business Overview
6.4.3 Fluidigm Biochips (Microarrays & Microfluidics) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fluidigm Biochips (Microarrays & Microfluidics) Product Portfolio
6.4.5 Fluidigm Recent Developments/Updates
6.5 Illumina
6.5.1 Illumina Corporation Information
6.5.2 Illumina Description and Business Overview
6.5.3 Illumina Biochips (Microarrays & Microfluidics) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Illumina Biochips (Microarrays & Microfluidics) Product Portfolio
6.5.5 Illumina Recent Developments/Updates
6.6 GE Healthcare
6.6.1 GE Healthcare Corporation Information
6.6.2 GE Healthcare Description and Business Overview
6.6.3 GE Healthcare Biochips (Microarrays & Microfluidics) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GE Healthcare Biochips (Microarrays & Microfluidics) Product Portfolio
6.6.5 GE Healthcare Recent Developments/Updates
6.7 Bio-Rad Laboratories
6.6.1 Bio-Rad Laboratories Corporation Information
6.6.2 Bio-Rad Laboratories Description and Business Overview
6.6.3 Bio-Rad Laboratories Biochips (Microarrays & Microfluidics) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bio-Rad Laboratories Biochips (Microarrays & Microfluidics) Product Portfolio
6.7.5 Bio-Rad Laboratories Recent Developments/Updates
6.8 Cepheid
6.8.1 Cepheid Corporation Information
6.8.2 Cepheid Description and Business Overview
6.8.3 Cepheid Biochips (Microarrays & Microfluidics) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cepheid Biochips (Microarrays & Microfluidics) Product Portfolio
6.8.5 Cepheid Recent Developments/Updates
6.9 Thermo Fisher
6.9.1 Thermo Fisher Corporation Information
6.9.2 Thermo Fisher Description and Business Overview
6.9.3 Thermo Fisher Biochips (Microarrays & Microfluidics) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Thermo Fisher Biochips (Microarrays & Microfluidics) Product Portfolio
6.9.5 Thermo Fisher Recent Developments/Updates
6.10 Roche
6.10.1 Roche Corporation Information
6.10.2 Roche Description and Business Overview
6.10.3 Roche Biochips (Microarrays & Microfluidics) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Roche Biochips (Microarrays & Microfluidics) Product Portfolio
6.10.5 Roche Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biochips (Microarrays & Microfluidics) Industry Chain Analysis
7.2 Biochips (Microarrays & Microfluidics) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biochips (Microarrays & Microfluidics) Production Mode & Process
7.4 Biochips (Microarrays & Microfluidics) Sales and Marketing
7.4.1 Biochips (Microarrays & Microfluidics) Sales Channels
7.4.2 Biochips (Microarrays & Microfluidics) Distributors
7.5 Biochips (Microarrays & Microfluidics) Customers
8 Biochips (Microarrays & Microfluidics) Market Dynamics
8.1 Biochips (Microarrays & Microfluidics) Industry Trends
8.2 Biochips (Microarrays & Microfluidics) Market Drivers
8.3 Biochips (Microarrays & Microfluidics) Market Challenges
8.4 Biochips (Microarrays & Microfluidics) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
